Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

More articles from Accelerated Communication

  • You have access
    Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures
    Laura K. K. Pacey, Scott P. Heximer and David R. Hampson
    Molecular Pharmacology July 2009, 76 (1) 18-24; DOI: https://doi.org/10.1124/mol.109.056127
  • You have access
    Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin
    Masahiro Tsuda, Tomohiro Terada, Tomoyuki Mizuno, Toshiya Katsura, Jin Shimakura and Ken-ichi Inui
    Molecular Pharmacology June 2009, 75 (6) 1280-1286; DOI: https://doi.org/10.1124/mol.109.056242
  • You have access
    Di(2-ethylhexyl) phthalate Is a Highly Potent Agonist for the Human Constitutive Androstane Receptor Splice Variant CAR2
    Joshua G. DeKeyser, Michael C. Stagliano, Scott S. Auerbach, K. Sandeep Prabhu, A. Daniel Jones and Curtis J. Omiecinski
    Molecular Pharmacology May 2009, 75 (5) 1005-1013; DOI: https://doi.org/10.1124/mol.108.053702
  • You have access
    Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain
    S. Chiechio, M. Zammataro, M. E. Morales, C. L. Busceti, F. Drago, R. W. Gereau, A. Copani and F. Nicoletti
    Molecular Pharmacology May 2009, 75 (5) 1014-1020; DOI: https://doi.org/10.1124/mol.108.054346
  • You have access
    Long-Term Morphine Treatment Decreases the Association of μ-Opioid Receptor (MOR1) mRNA with Polysomes through miRNA23b
    Qifang Wu, Lei Zhang, Ping-Yee Law, Li-Na Wei and Horace H. Loh
    Molecular Pharmacology April 2009, 75 (4) 744-750; DOI: https://doi.org/10.1124/mol.108.053462
  • You have access
    5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a Phospholipase D Pharmacological Inhibitor That Alters Cell Spreading and Inhibits Chemotaxis
    Wenjuan Su, Oladapo Yeku, Srinivas Olepu, Alyssa Genna, Jae-Sook Park, Hongmei Ren, Guangwei Du, Michael H. Gelb, Andrew J. Morris and Michael A. Frohman
    Molecular Pharmacology March 2009, 75 (3) 437-446; DOI: https://doi.org/10.1124/mol.108.053298
  • You have access
    D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
    Asha Sahu, Kimberly R. Tyeryar, Habiba O. Vongtau, David R. Sibley and Ashiwel S. Undieh
    Molecular Pharmacology March 2009, 75 (3) 447-453; DOI: https://doi.org/10.1124/mol.108.053017
  • You have access
    Nuclear Xenobiotic Receptor Pregnane X Receptor Locks Corepressor Silencing Mediator for Retinoid and Thyroid Hormone Receptors (SMRT) onto the CYP24A1 Promoter to Attenuate Vitamin D3 Activation
    Yoshihiro Konno, Susumu Kodama, Rick Moore, Nobuhiro Kamiya and Masahiko Negishi
    Molecular Pharmacology February 2009, 75 (2) 265-271; DOI: https://doi.org/10.1124/mol.108.051904
  • You have access
    Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels
    Wienke Lange, Jan Geißendörfer, Anne Schenzer, Joachim Grötzinger, Guiscard Seebohm, Thomas Friedrich and Michael Schwake
    Molecular Pharmacology February 2009, 75 (2) 272-280; DOI: https://doi.org/10.1124/mol.108.052282
  • You have access
    Targeting Ceramide Metabolism with a Potent and Specific Ceramide Kinase Inhibitor
    Christine Graf, Martin Klumpp, Michael Habig, Philipp Rovina, Andreas Billich, Thomas Baumruker, Berndt Oberhauser and Frédéric Bornancin
    Molecular Pharmacology October 2008, 74 (4) 925-932; DOI: https://doi.org/10.1124/mol.108.048652

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 19
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics